Well to put some of this into presepctive:
Ted seems to be talking about a trickle of a few tens of thousands of dollars which barely cost the regulatory cost of running a public company, so clearly nothing on business development.
Ted seems to be trying to take credit for sales that AB announced he had initiated in his 26 Oct 2017 ASX announcement. There have cerainly been no sales or revenues ever in the histoyr of this company and AB's impetus seems to have been the necessary spark.
A lot of talk again about how their JV partner is struggling still after 6 years to make a go of it and are only funded up, now, again, because one of the PPY directors is doing their job for them.
Interesting to see that AB resigned because of intervention by the chairman, any CEO would do the same. It is not the directors' job to second guess the person they hire to do the executive management, certainly not this group of what their history suggests to me are neardowells.
- Forums
- ASX - By Stock
- PPY
- Ann: Chairman's Address to Shareholders
Ann: Chairman's Address to Shareholders, page-2
Featured News
Add PPY (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.897M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 176922 | 1.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.4¢ | 199999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 176922 | 0.012 |
1 | 300000 | 0.011 |
3 | 530005 | 0.010 |
3 | 649555 | 0.009 |
2 | 172533 | 0.008 |
Price($) | Vol. | No. |
---|---|---|
0.014 | 199999 | 1 |
0.018 | 160871 | 1 |
0.019 | 500770 | 1 |
0.020 | 105000 | 2 |
0.021 | 25000 | 1 |
Last trade - 16.12pm 12/11/2024 (20 minute delay) ? |
Featured News
PPY (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online